Dare Bioscience, Inc. (DARE)
NASDAQ·Healthcare·Biotechnology
$0.82
-3.45%
Mkt Cap $11.40M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+1362.2%
Consensus $12.00 vs current $0.82
NASDAQ·Healthcare·Biotechnology
$0.82
-3.45%
Mkt Cap $11.40M
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
+1362.2%
Consensus $12.00 vs current $0.82